An observational study in FSH Hypersecretion, Endocrine System Diseases and Infertility, sponsored by Clear Passage Therapies, Inc. Terminated at 1 site in United States. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2015-01-26.
Sponsored by Clear Passage Therapies, Inc · Observational
This study will examine the impact of manual physical therapy on endocrine function in women diagnosed as being infertile due to elevated follicle stimulating hormone (FSH) levels (10 mIU/mL or higher) on days 2-5 of their menstrual cycle. It is hypothesized that the manual physical therapy will decrease FSH levels.
This study will investigate the effect of manual physical therapy on the endocrine levels of women by comparison of pre- and post- treatment hormone levels (FSH, LH and Estradiol). Secondary measures include assessment of pain and sexual function via questionnaires.
Hormones will be measured at prescribed time points:
Pain and sexual function questionnaires will be completed:
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's enrollment of 1 is below the median of 200 across 714 observational studies indexed under Infertility.
Browse Infertility studies →Clear Passage Therapies, Inc is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women with elevated FSH levels that undergo the CPA treatment
Exclusion Criteria:
CPA treatment group receives 20 hours of patient centered manual physical therapy
Other: CPA
Site specific, patient centered manual physical therapy regimen focused on restoring function to the entire body
Also known as: Clear Passage Approach, Wurn Technique
Change in endocrine levels post treatment
Change in FSH, LH and estradiol levels from baseline and pre-treatment, baseline and 30 and 60 day post treatment.
Time frame: baseline, pre-treatment and 30 and 60 days post treatment
Pain levels and sexual function before treatment
Pain levels and sexual function before treatment as compared to baseline.
Time frame: 30 days before treatment
Pain levels and sexual function post treatment
Pain levels and sexual function as measured by survey 30 days post treatment compared to baseline.
Time frame: 30 days post treatment
Pain levels and sexual function post treatment
Pain levels and sexual function as measured by survey 60 days post treatment compared to baseline.
Time frame: 60 days post treatment
Pregnancy
Subjects will be monitored for natural intrauterine pregnancy for the duration of the study.
Time frame: study duration; 60 days post treatment
This study is terminated, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Clear Passage Therapies, Inc